Methodist Hospitals, Gary, Indiana (Ms DeVries); Alliance for Vascular Access Teaching and Research, Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia (Ms DeVries); Infection Control, Methodist Hospitals, Gary, Indiana (Dr Scott).
Michelle DeVries, MPH, CIC, VA-BC, has been involved in infection prevention and hospital epidemiology for more than 25 years, with a career spanning community, university, and federal health care systems. With a background in hospital and molecular epidemiology, her focus has been at the intersection of vascular access, patient safety, and infection prevention. She was a reviewer for the 2016 and 2021 Infusion Therapy Standards of Practice, wrote the Device Associated Infections chapter for the International Federation of Infection Control textbook, and contributed 2 chapters to the Vessel Health and Preservation text. She has numerous peer-reviewed and invited journal contributions. She is a former director with the Vascular Access Certification Board, currently serving on the National Association for Vascular Access (AVA) Board, and she serves as copresident of her local AVA Network (HoosierVAN). She is an adjunct research fellow with the Alliance for Vascular Access Teaching and Research and has traveled extensively, sharing her approaches to reducing harm with all vascular access devices.
Nancy Scott, DNP, ACNS-BC, CIC, VA-BC, PCCN, CNRN, SCRN, has been practicing as a registered nurse for 39 years and has been a clinical nurse specialist for 13 years. She has also served as an infection preventionist for 7 years in community, university, and academic settings, focusing on the translation of knowledge and integrations of evidence-based practice supporting patient safety. With her background as a clinical nurse and advanced practice nurse in professional development, she has worked with organizations, staff, students, and multidisciplinary teams to implement evidence-based protocols supporting quality patient outcomes. She sought additional certification in vascular access to aid her as she works with a team to improve vascular access device selection, insertion, and care. As a member of the local AVA chapter, she has had the opportunity to draw on experts in vascular access to pose questions and address opportunities.
Corresponding Author: Michelle DeVries MPH, CIC, VA-BC, Senior Infection Control Officer, Methodist Hospitals, 600 Grant St, Gary, IN 46402 ([email protected]).
Disclosures: This study was funded by an investigator-initiated grant initiated by Ms DeVries and by Johnson & Johnson. Ms DeVries discloses relationships with 3M, Baxter, B Braun, BD, Eloquest, Ethicon, Smiths Medical (now ICU Medical), and Teleflex. Dr Scott has nothing to declare.
